[DOI] [PMC free article] [PubMed] [Google Scholar] 120.Louie S.M., Grossman E.A., Crawford L.A., Ding L., Camarda R., Huffman T.R., Miyamoto D.K., Goga A., Weerapana E., Nomura D.K
TCBZ failure and resistance is increasingly being reported in many countries, raising concerns of how to control the disease in the absence of new flukicides and vaccines 6
Although a trend toward reduced HCC risk was observed, this failed to achieve statistical significance in the overall analysis (IRR: 0.82, 95%CI: 0.61-1.11, P = 0.189), possibly reflecting insufficient follow-up duration to capture the full impact on hepatocarcinogenesis
These examples reflect injuries that have been reported or alleged in connection with GLP-1 drug use and are provided for general informational purposes only
Compare Prices: Shop around at different pharmacies to compare prices